Ryne Biotechnology Revenue and Competitors
Estimated Revenue & Valuation
- Ryne Biotechnology's estimated annual revenue is currently $775k per year.
- Ryne Biotechnology's estimated revenue per employee is $77,500
Employee Data
- Ryne Biotechnology has 10 Employees.
- Ryne Biotechnology grew their employee count by 43% last year.
Ryne Biotechnology's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Medical Officer, Scientific Co-Founder and Director | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | CMO & Scientific Co-Founder | Reveal Email/Phone |
4 | Scientific Co-Founder | Reveal Email/Phone |
5 | CTO | Reveal Email/Phone |
6 | Program Director | Reveal Email/Phone |
7 | Associate Director, Translational Biology | Reveal Email/Phone |
Ryne Biotechnology Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Ryne Biotechnology?
Ryne Bio is a biotechnology company advancing off-the-shelf neuron replacement therapies as potent disease-modifying treatments for neurological disorders. To achieve this we leverage induced pluripotent stem cell (iPSC) technology, which enables precision manufacture of therapeutically relevant human neurons. Our lead program targeting Parkinson’s Disease is a cryopreserved iPSC dopamine neuron progenitor (RNDP-001) that can be reliably manufactured and delivered.
keywords:N/AN/A
Total Funding
10
Number of Employees
$775k
Revenue (est)
43%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.9M | 10 | N/A | N/A |
#2 | $0.9M | 10 | N/A | N/A |
#3 | $2.5M | 10 | 0% | N/A |
#4 | $0.9M | 10 | 400% | N/A |
#5 | $0.6M | 10 | -62% | N/A |